Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Archana Ajmera

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical CenterNicole Farha, Katarina Vasiljevic, Shelly Kane, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical CenterNicole Farha, Katarina Vasiljevic, Shelly Kane, et al.
JCO Oncology Practice|March 8, 2024
Virtual Follow-Up in Patients Initiating Antineoplastic Treatment in the Ambulatory SettingLauren J Chew, Danielle S Urman, Kevin Maxwell, et al.
Cancer|June 19, 2026
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparibRana R McKay, Wanling Xie, Archana Ajmera, et al.
Molecular Cancer Therapeutics|February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Journal for Immunotherapy of Cancer|March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2026
Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)Rana R McKay, Wanling Xie, Archana Ajmera, et al.
The Oncologist|June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following ImmunotherapyJustine Panian, Ava Saidian, Kevin Hakimi, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Cancer|February 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort studyCecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|March 31, 2026
QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical CenterNicole Farha, Katarina Vasiljevic, Shelly Kane, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 16, 2026
QIM26-301: Implementation of a Same-Day Cancer Care Clinic at an Academic Medical CenterNicole Farha, Katarina Vasiljevic, Shelly Kane, et al.
JCO Oncology Practice|March 8, 2024
Virtual Follow-Up in Patients Initiating Antineoplastic Treatment in the Ambulatory SettingLauren J Chew, Danielle S Urman, Kevin Maxwell, et al.
Cancer|June 19, 2026
Patient-reported outcomes in castration-resistant prostate cancer with bone metastases treated with radium-223 with or without olaparibRana R McKay, Wanling Xie, Archana Ajmera, et al.
Molecular Cancer Therapeutics|February 13, 2023
A Phase I Study of Combination Olaparib and Radium-223 in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) with Bone Metastases (COMRADE)Elizabeth Pan, Wanling Xie, Archana Ajmera, et al.
Journal for Immunotherapy of Cancer|March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2026
Multicenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)Rana R McKay, Wanling Xie, Archana Ajmera, et al.
The Oncologist|June 27, 2023
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following ImmunotherapyJustine Panian, Ava Saidian, Kevin Hakimi, et al.
Cancers|September 9, 2022
Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort StudyMichael J Wagner, Cassandra Hennessy, Alicia Beeghly, et al.
Cancer|February 20, 2024
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort studyCecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, et al.
Pageof 1